te Plan to collect blood samples through drones in evaluation stage, Dr. Lal PathLabs CEO Om Manchanda tells Zee Business | Zee Business

Plan to collect blood samples through drones in evaluation stage, Dr. Lal PathLabs CEO Om Manchanda tells Zee Business

Zee Business Executive Editor Swati Khandelwal Jain spoke with Om Manchanda, CEO of Dr. Lal PathLabs in a special Tv show 'Corporate Radar'.

Plan to collect blood samples through drones in evaluation stage, Dr. Lal PathLabs CEO Om Manchanda tells Zee Business
A leading blood test laboratory in India, Dr. Lal PathLabs Limited has announced that they are planning to transport blood samples using a drone.

A leading blood test laboratory in India, Dr. Lal PathLabs Limited has announced that they are planning to transport blood samples using a drone. What is the thought process behind this plan? What is the whole idea? Zee Business Executive Editor Swati Khandelwal Jain spoke with Om Manchanda, CEO of Dr. Lal PathLabs in a special Tv show 'Corporate Radar'.

Talking about the project, Manchanda said that the plan to transfer blood samples through drones is still in the evaluation stage. Actually, its pilot project has not even started yet. The company will start it only when it gets all the approvals.

See Zee Business Live TV Streaming Below:

TRENDING NOW

He refused to comment on this as the plan is at a very early stage. He said DR Lal PathLabs has been approached by a company which manufactures drones.

He further said that there are many places in the country, especially in hilly areas, where it takes a long time to collect samples. So, this scheme can be used as emergency services.

'It is too early for me to comment anything on this. This is going to take a lot of time. Right now this is in a feasibility stage because there are a lot of companies approaching us who are in this business. And we also have to see what is the regulatory requirement. So, I would really say it's too early. It's just in the feasibility and evaluation phase,' the CEO said.

The company, which started in the year 1949, is one of the largest diagnostic chains in the country. The company has more than 5000 tests and services on its list. It has 230 clinical labs, 3,700 patient care centers, and more than 9000 pickup points across the country. I have a very large PR presence across India.

For More Details Watch Full Video Here:

 

Written By: ZeeBiz WebTeam
Edited By: Shivendra Kumar
Updated: Wed, Apr 13, 2022
09:27 pm
ZeeBiz WebDesk
RELATED NEWS
Dr Lal Pathlabs, Thyrocare, other diagnostic test stocks rise after Centre issues guidelines on JN.1 COVID-19 variant Dr Lal Pathlabs, Thyrocare, other diagnostic test stocks rise after Centre issues guidelines on JN.1 COVID-19 variant
Dr Lal PathLabs shares continue to rise for second straight day after medical diagnostics firm stages strong Q2 show Dr Lal PathLabs shares continue to rise for second straight day after medical diagnostics firm stages strong Q2 show
Dr Lal PathLabs Q2 Results: Net profit rises 54% to Rs 111 crore Dr Lal PathLabs Q2 Results: Net profit rises 54% to Rs 111 crore
Dr Lal Pathlabs shares plummet over 8 per cent after Q2 results: Check brokerage report Dr Lal Pathlabs shares plummet over 8 per cent after Q2 results: Check brokerage report
Momentum to continue in healthcare stocks, brokerages say; diagnostic companies’ shares surge up to 10% intraday Momentum to continue in healthcare stocks, brokerages say; diagnostic companies’ shares surge up to 10% intraday

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x